Activist Investor Velibor Krstic Increases Warrant Stake to 16.2% and Demands Mandatory Exchange Before May 7 Expiration

summarizeSummary

Activist investor Velibor Krstic has increased his stake in Strata Critical Medical's public warrants to 16.21% and is demanding a mandatory exchange of warrants before their May 7, 2026 expiration, citing strong company fundamentals and potential breach of fiduciary duty by the board.

check_boxKey Events

• Increased Activist Stake in Warrants

  Velibor Krstic has increased his beneficial ownership of Strata Critical Medical's public warrants to 1,485,877, representing approximately 16.21% of the outstanding public warrants. This follows previous disclosures on April 7 and April 8, 2026.

• Demand for Mandatory Warrant Exchange

  The investor is explicitly calling for a mandatory exchange of the public warrants via an amendment to the Warrant Agreement, emphasizing it as the only rational solution to stabilize the capital structure before the May 7, 2026 expiration.

• Accusations of Fiduciary Duty Breach

  Krstic states that with the company's strong market valuation and record fundamentals, the board's inaction regarding the warrants would be interpreted as "premeditated destruction of value and a breach of fiduciary duty."

• Highlights Strong Company Fundamentals

  The filing highlights Strata Critical Medical's position as a market leader, record 2025 results with $14.1 million Adjusted EBITDA, a raised 2026 Adjusted EBITDA target of $29-33 million, and over $110 million in total liquidity.

auto_awesomeAnalysis

This Schedule 13D/A filing marks a significant escalation in Velibor Krstic's activist campaign, following previous disclosures on April 7 and April 8, 2026. Krstic has increased his beneficial ownership of Strata Critical Medical's public warrants to 16.21% and is now explicitly demanding a mandatory exchange of these warrants to stabilize the capital structure before their May 7, 2026 expiration. The investor highlights the company's strong financial performance and liquidity, arguing that inaction by the board would constitute a "premeditated destruction of value and a breach of fiduciary duty." This puts direct pressure on the board to address the warrant situation, potentially leading to a material change in the company's capital structure and warrant holder value.